Solence Secures €1.6 Million to Advance Digital Therapy for PCOS
Paris, France – July 11, 2025 – Solence, a pioneering health-tech company, has successfully raised €1.6 million in a significant funding round, as reported by FrenchWeb. This capital injection is earmarked for the widespread deployment of its innovative digital therapy designed to combat Polycystic Ovary Syndrome (PCOS).
PCOS is a complex hormonal disorder affecting women of reproductive age, often leading to a range of health challenges including irregular periods, infertility, and metabolic issues. Solence’s approach leverages the power of digital technology to provide personalized, accessible, and evidence-based support for individuals managing this chronic condition.
The €1.6 million raised signifies strong investor confidence in Solence’s vision and its potential to revolutionize the way PCOS is managed. This funding will be instrumental in scaling the company’s operations, further developing its digital therapeutic platform, and expanding its reach to a larger patient population.
While specific details regarding the investor consortium were not immediately available, this successful fundraising effort underscores the growing recognition of digital health solutions as a crucial component of modern healthcare. Solence’s commitment to addressing the unmet needs of women with PCOS through a digital-first strategy positions the company as a key player in the evolving landscape of women’s health.
With this substantial investment, Solence is poised to make a tangible impact on the lives of individuals affected by PCOS, offering a novel and empowering approach to treatment and management. The company’s dedication to innovation and patient well-being is set to drive forward a new era of accessible and effective care for this prevalent condition.
Solence lève 1,6 million d’euros pour déployer sa thérapie numérique contre le SOPK
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
FrenchWeb published ‘Solence lève 1,6 million d’euros pour déployer sa thérapie numérique contre le SOPK’ at 2025-07-11 04:34. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.